Katie studied biochemistry at the University of Oxford, before joining a lab to investigate why the immune system can’t control HIV. She then worked in science communication for the MS Society and joined Cancer Research UK’s News and Content team in 2017, where she writes for the blog and news feed.
A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS.
New computer simulation study suggests only screening women deemed at a ‘high risk’ of breast cancer could help to reduce unnecessary diagnoses.
This week’s headlines: drug could protect children from hearing loss after chemo and cancer rates in over-75s are ‘set to rocket’.
Top stories this week: A breast cancer immunotherapy first and lung cancer immunotherapy approved for NHS use in England.
This week’s top stories: HPV vaccine is safe and effective and London Mayor to ban junk food ads on public transport.
Questions are being asked of the tests used to diagnose prostate cancer, and how they can be improved. We cover the latest research, including specialist MRI.
Headlines today have linked mobile use to brain tumours, but the claims don’t match the study they’re covering.
In the news this week: ‘sugar tax’ on soft drinks and scientists publish results from the largest ever genetic analysis of cancer.
In the news this week: teenagers exposed to junk food ads are twice as likely to be obese and new child vaping research